Ana Matos joined several challenging research projects in distinct scientific areas under the framework of bachelor, master and PhD projects, and internship and research fellowships, at different faculties and research institutes. Her first contact with research occurred during her bachelor project in the nanotechnology field. Thereafter, she could apply the know-how acquired in the nanotechnology area to biosensing and immunosensing and extend her knowledge in techniques as ellipsometry, surface plasmon resonance, electrochemical methods and atomic force microscopy. She also worked at the IAESTE funded research project based on antioxidant, anti-inflammatory and anticholinesterase activity of medicinal plants, in Brazil for 4 months. Thereafter, she joined the BioNanoSciences–Drug Delivery & Immunotherapy group at iMed.ULisboa to work on the MSc research project based on the development of nanosystems for HIV vaccine delivery where she could extend her expertise in virology and immunology fields and cell culture, confocal microscopy and flow cytometry. Moreover, the desire to deeply engage in the nanotechnology, immunotherapy and oncology research fields resulted in a challenging PhD project, where she assessed the immunotherapeutic efficacy in vivo of developed nanovaccines alone and in combination with modulators of the immunosuppressive tumor-immune microenvironment and tumor-associated vasculature, in immune-competent cancer mouse models. She also developed a microfluidic cell chip as a preclinical ex vivo model system alternative to in vivo studies, to enable the rapid screening of the best anti-cancer treatment. Currently, she is a postdoctoral researcher under the framework of the Healthcare Research call 2019 (LCF/PR/HR19/52160021; NanoPanther) funded by “la Caixa” Foundation.